GANCICLOVIR (EXELA PHARMA SCIENCES, LLC)
Welcome to the PulseAid listing for the GANCICLOVIR drug offered from EXELA PHARMA SCIENCES, LLC. This Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | EXELA PHARMA SCIENCES, LLC |
| NON-PROPRIETARY NAME: | GANCICLOVIR |
| SUBSTANCE NAME: | GANCICLOVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-02-28 |
| END MARKETING DATE: | 0000-00-00 |
GANCICLOVIR HUMAN PRESCRIPTION DRUG Details:
| Item Description | GANCICLOVIR from EXELA PHARMA SCIENCES, LLC |
| LABELER NAME: | EXELA PHARMA SCIENCES, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 2017-02-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51754-2500_238a983f-81bb-4033-b6ca-5fee7d6d291c |
| PRODUCT NDC: | 51754-2500 |
| APPLICATION NUMBER: | NDA209347 |
Other GANCICLOVIR Pharmaceutical Manufacturers / Labelers:
